Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FluMist manufacturing facility cited

Executive Summary

FDA issues MedImmune a warning letter citing the company for manufacturing deficiencies at its Liverpool, U.K. facility, including failure to implement a program to control microbial contamination of eggs used to make FluMist. FDA does not expect lower availability of the flu vaccine for the 2007-2008 flu season, unlike the 2004-2005 season when GMP violations by Chiron caused a shortage...

You may also be interested in...



FDA Relaxes Restrictions on Live Vaccine Processing

Manufacturers of live vaccines such as those for influenza will soon be able to rely solely on process controls and, where necessary, process containment, to prevent cross-contamination of live vaccine organisms, under a recent direct final rule by FDA

Long Hot Summer For Novel Drug Reviews Forecast At US FDA

Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.

Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza

The latest drug development news and highlights from our US FDA Performance Tracker.

UsernamePublicRestriction

Register

PS048425

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel